MedTrace Logo

The Effect of Fontan Fenestration Closure on Hepatic Stiffness

NCT03481985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2023-04-19

No results posted yet for this study

Summary

The overarching goal of this project is to discern how closure of Fontan fenestrations in patients with single ventricle heart disease will affect hepatic congestion, a major determinant of chronic liver disease. We will employ transient elastography (Fibroscan) to obtain liver stiffness measurements (LSM) before and after fenestration closure to study the impact of this intervention on hepatic congestion.

Conditions

  • Single-ventricle
  • Hepatic Congestion

Interventions

OTHER

Fenestration status

The exposure variable will be status of the Fontan fenestration

Sponsors & Collaborators

Principal Investigators

  • Rahul Rathod, MD · Cardiologist/Principal Investigator

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-29
Primary Completion
2021-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03481985 on ClinicalTrials.gov